MedPath

Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study

Recruiting
Conditions
Placenta Previa
Registration Number
NCT05802251
Lead Sponsor
Ain Shams University
Brief Summary

The aim of this study is to evaluate the effectiveness of ultrasonographic parameters (cervical length, placental thickness and distance placental edge from internal os of the cervix) in predicting the risk of antepartum hemorrhage and emergency cesarean delivery in asymptomatic women with placenta previa.

Detailed Description

The incidence of placenta previa is 3-5 per 1000 pregnancies worldwide and is still rising because of increased maternal age, parity, cesarean section rates, assisted reproductive technology, maternal smoking with the widespread use of transvaginal ultrasound. antepartum hemorrhage is an important cause of maternal and neonatal morbidity and mortality in pregnant women with placenta previa. However, the epidemiological characteristics are not completely understood. this study aims at evaluating the sonographic findings in asymptomatic women with placenta previa as cervical length, placenta thickness and distance from cervix to placental edge to recommend management for in-patients versus out-patient antenatal care and early planned hospital admission and delivery for women at high risk of antepartum hemorrhage and preterm cesarean section and hysterectomy for life threatening antepartum hemorrhage.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
68
Inclusion Criteria
  • Asymptomatic women diagnosed with placenta previa according to RCOG (GTG No. 27a, 2018): placenta lies directly over the internal os for pregnancies more than 16 weeks' gestation on transabdominal or transvaginal scanning.
  • Gestational age between 28 till 37 weeks' gestation (as delivery should be considered between 36 and 37 weeks of gestation for women presenting with uncomplicated placenta previa)
Exclusion Criteria
  • Multiple pregnancies.
  • Threatened preterm labor or preterm rupture of membranes.
  • History of bleeding in the current pregnancy.
  • Polyhydraminos (AFI > 25 cm).
  • History of cervical surgery (cone biopsy).
  • Presence of cervical cerclage.
  • Maternal use of vaginla progesterone.
  • History of maternal disease (hypertensive, DM, Cardiac).
  • Fetal malformation or growth restriction

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
maternal bleeding ratetill delivery

number of attacks of antepartum hemorrhage

Secondary Outcome Measures
NameTimeMethod
Emergency Cesarean sectiontill delivery 36 to 37 weeks

severe antepartum hemorrhage requiring delivery

Blood transfusiontill delivery 36 to 37 weeks

number of PRBCs

Premature delivery37 week's gestation

before the planned delivery date (before 37 weeks' gestation)

Postpartum hemorrhageWithin 2 hours of delivery

severity of attacks and required further management or blood transfusion

Need for cesarean hysterectomyduring cesarean section

cesarean hysterectomy due to bleeding or placenta accreta spectrum

Trial Locations

Locations (1)

Faculty of Medicine, Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath